Engineers in Silicon Valley have been raving about Anthropic’s AI coding tool, Claude Code, for months. But recently, the buzz feels as if it’s reached a fever pitch. Earlier this week, I sat down ...

Microsoft sells GitHub Copilot to its customers, but it increasingly favors Claude Code internally. Microsoft sells GitHub Copilot to its customers, but it increasingly favors Claude Code internally.

ChatGPT may be the best-known artificial intelligence chatbot on the market, but the latest iteration of AI startup Anthropic’s coding bot, Claude Code, is newly entering the spotlight. By simplifying ...

Claude Code generates computer code when people type prompts, so those with no coding experience can create their own programs and apps. By Natallie Rocha Reporting from San Francisco Claude Code, an ...

Vibe coding trades creativity for coordination and oversight. Performance and UI issues still demand human judgment. AI shines when developers relentlessly lead, test, and correct. Over all my years ...

Microsoft is having thousands of its software engineers test Anthropic's Claude Code alongside its own GitHub Copilot. This move signals growing confidence in Anthropic's AI coding tools, even as ...

The original HyperX Cloud Mix Buds were nifty gaming earbuds with batteries that could survive 10-hour sessions. For the follow-up HyperX has swapped that juice – they now last just seven hours – for ...

Add Yahoo as a preferred source to see more of our stories on Google. This National Weather Service diagram shows how air temperatures at different levels in the atmosphere can determine what kind of ...

Add Yahoo as a preferred source to see more of our stories on Google. Sci-Fi horror has always held a special special in my heart, and there's nothing better (or worse) than deep space. The vacuum of ...

We independently review everything we recommend. When you buy through our links, we may earn a commission. Learn more› By Mace Dent Johnson Mace Dent Johnson is a writer on the kitchen team. To test ...

2025 was a challenging year for the UK biotech sector, but it ended the year with signs of "renewed confidence and broadening investor appetite." That is the conclusion of the annual assessment of the ...

The first data has emerged on the uptake of Novo Nordisk's new oral version of GLP-1 agonist weight-loss therapy Wegovy, with encouraging signs of strong demand as a potential rival from Eli Lilly ...